Processa Pharmaceuticals, Inc. (PCSA) Social Stream



Processa Pharmaceuticals, Inc. (PCSA): $1.90

0.04 (-2.06%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add PCSA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#174 of 360

in industry

PROCESSA PHARMACEUTICALS INC (PCSA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PCSA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 2 $22 $15 $18.5 $0.288 6323.61%
2022-01-27 1 $17 $17 $17 $0.288 5802.78%
2022-04-22 2 $17 $9 $13 $0.288 4413.89%
2022-05-13 2 $17 $9 $11.666 $0.288 3950.69%
2022-05-27 3 $17 $9 $11.666 $0.288 3950.69%
2022-08-15 3 $11 $9 $9.666 $0.288 3256.25%
2022-09-15 3 $9 $8 $8.666 $0.288 2909.03%
2022-11-10 3 $9 $5 $7.666 $0.288 2561.81%
2023-01-13 3 $9 $5 $6.333 $0.288 2098.96%
2023-04-03 3 $9 $3 $5.666 $0.288 1867.36%
2023-04-04 2 $4 $4 $4 $0.288 1288.89%
2023-04-06 3 $5 $3 $4 $0.288 1288.89%
2023-06-02 2 $4 $2 $3 $0.288 941.67%
2023-10-13 2 $4 $1 $2.5 $0.288 768.06%

The Trend in the Analyst Price Target


PCSA's average price target has moved down $14.5 over the prior 30 months.

Over the past 39 weeks, PCSA's average upside potential has been 696.44%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-13 3 9 5 6.333 1.25 406.64%
2023-04-04 2 5 3 4.000 0.49 716.33%
2023-04-04 3 4 4 4.000 0.49 716.33%
2023-04-04 2 4 4 4.000 0.49 716.33%
2023-04-06 2 5 3 4.000 0.47 751.06%

PCSA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


PCSA's average broker recommendation rating improved by 1 over the prior 34 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • PCSA has a higher upside potential (average analyst target price relative to current price) than 1877.47% of all US stocks.
  • In terms of how PROCESSA PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 79.65% of that group.
  • PROCESSA PHARMACEUTICALS INC's average analyst price target is greater than 298.35% of Healthcare stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PROCESSA PHARMACEUTICALS INC's variance in analysts' estimates is lower than -448.54% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PROCESSA PHARMACEUTICALS INC are MNPR, CNSP, and TRVI.

Make investment decisions regarding PCSA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!